• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human N-acetylgalactosamine kinase (GALK2)

ACP24506

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP24506 Target NameGALK2
Target SynonymsGALK2; GaINAc Kinase; Galactokinase 2; Galk2; GALK2_HUMAN; GalNAc kinase; GK2; MGC1745; N-acetylgalactosamine kinaseFormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Expression Range1-458
Protein LengthFull length proteinPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ01415
Background Information
  • Uniprot Id

    Q01415

  • Target Species

    Human

  • Target Name

    GALK2

  • Target Full Name

    N-acetylgalactosamine kinase

  • Target Function

    Acts on GalNAc. Also acts as a galactokinase when galactose is present at high concentrations. May be involved in a salvage pathway for the reutilization of free GalNAc derived from the degradation of complex carbohydrates.

  • Target Protein Families

    GHMP kinase family, GalK subfamily

  • Target Synonyms

    GALK2; GaINAc Kinase; Galactokinase 2; Galk2; GALK2_HUMAN; GalNAc kinase; GK2; MGC1745; N-acetylgalactosamine kinase

  • Target Background

    This gene encodes a highly efficient N-acetylgalactosamine (GalNAc) kinase, which has galactokinase activity when galactose is present at high concentrations. The encoded protein is a member of the GHMP kinase family. Alternative splicing results in multiple transcript variants.

Inquire Recombinant Human N-acetylgalactosamine kinase (GALK2) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification